Submit Deal

ATALANTA THERAPEUTICS

HQ - Boston

Summary

Atalanta Therapeutics is a biopharmaceutical company specializing in pioneering treatments for neurodegenerative diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 78 M

Avg. Deal Size£ 78 M

Market Context

Senior Management

Sort

Target: ATALANTA THERAPEUTICS

Bidder: SANOFI VENTURES

6 Service Providers

10 Dealmakers

£ 78 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy